Fully Decentralised Clinical Study Exploring Remote Collection of Glycaemic and Behaviometric Data Among Participants With Type 2 Diabetes Mellitus on Different Treatment Regimens is a registry-stage clinical asset sponsored by Novo Nordisk A/S in Diabetes Mellitus, Type 2. SEO and diligence focus: Oral antidiabetetic drugs, Basal insulin, Glucagon-like peptide-1 (GLP-1), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.